Clinical Trial Update: Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION) [NA]

View source ↗

Summary

The SOLUTION trial evaluating Y-3 delivered through the skull bone marrow for treatment of malignant middle cerebral artery infarction (a severe form of acute i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Middle Cerebral Artery Infarction
• Stroke

Drugs mentioned

• Y-3

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke, Acute Ischemic | NA | Status: COMPLETED